NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 90 filers reported holding NATERA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $5,975,000 | +32.8% | 289,764 | -10.1% | 0.31% | +14.3% |
Q4 2018 | $4,498,000 | -41.6% | 322,196 | +0.1% | 0.27% | -20.9% |
Q3 2018 | $7,705,000 | -8.9% | 321,843 | -28.4% | 0.34% | +4.2% |
Q2 2018 | $8,456,000 | +88.6% | 449,310 | -7.1% | 0.33% | +54.7% |
Q1 2018 | $4,484,000 | +2.7% | 483,663 | -0.4% | 0.21% | -1.4% |
Q4 2017 | $4,365,000 | -30.7% | 485,503 | -0.6% | 0.22% | -41.2% |
Q3 2017 | $6,296,000 | +20.5% | 488,453 | +1.6% | 0.37% | +5.4% |
Q2 2017 | $5,223,000 | +24.1% | 480,944 | +1.4% | 0.35% | +29.6% |
Q1 2017 | $4,208,000 | -29.5% | 474,453 | -7.0% | 0.27% | -39.6% |
Q4 2016 | $5,972,000 | -16.0% | 510,014 | -20.3% | 0.45% | -14.5% |
Q3 2016 | $7,110,000 | -18.7% | 639,961 | -11.7% | 0.52% | -29.8% |
Q2 2016 | $8,744,000 | +9.7% | 724,750 | -13.5% | 0.74% | +5.1% |
Q1 2016 | $7,973,000 | -8.6% | 837,477 | +3.7% | 0.71% | -13.7% |
Q4 2015 | $8,724,000 | +103.6% | 807,814 | +104.5% | 0.82% | +93.9% |
Q3 2015 | $4,285,000 | – | 394,956 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |